Literature DB >> 18317597

Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay.

Thomas Rio Frio1, Nicholas M Wade, Adriana Ransijn, Eliot L Berson, Jacques S Beckmann, Carlo Rivolta.   

Abstract

Dominant mutations in the gene encoding the mRNA splicing factor PRPF31 cause retinitis pigmentosa, a hereditary form of retinal degeneration. Most of these mutations are characterized by DNA changes that lead to premature termination codons. We investigated 6 different PRPF31 mutations, represented by single-base substitutions or microdeletions, in cell lines derived from 9 patients with dominant retinitis pigmentosa. Five of these mutations lead to premature termination codons, and 1 leads to the skipping of exon 2. Allele-specific measurement of PRPF31 transcripts revealed a strong reduction in the expression of mutant alleles. As a consequence, total PRPF31 protein abundance was decreased, and no truncated proteins were detected. Subnuclear localization of the full-length PRPF31 that was present remained unaffected. Blocking nonsense-mediated mRNA decay significantly restored the amount of mutant PRPF31 mRNA but did not restore the synthesis of mutant proteins, even in conjunction with inhibitors of protein degradation pathways. Our results indicate that most PRPF31 mutations ultimately result in null alleles through the activation of surveillance mechanisms that inactivate mutant mRNA and, possibly, proteins. Furthermore, these data provide compelling evidence that the pathogenic effect of PRPF31 mutations is likely due to haploinsufficiency rather than to gain of function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317597      PMCID: PMC2262031          DOI: 10.1172/JCI34211

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

Review 1.  Nonsense-mediated decay approaches the clinic.

Authors:  Jill A Holbrook; Gabriele Neu-Yilik; Matthias W Hentze; Andreas E Kulozik
Journal:  Nat Genet       Date:  2004-08       Impact factor: 38.330

2.  Dominant retinitis pigmentosa with reduced penetrance.

Authors:  E L Berson; P Gouras; R D Gunkel; N C Myrianthopoulos
Journal:  Arch Ophthalmol       Date:  1969-02

3.  Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13).

Authors:  A B McKie; J C McHale; T J Keen; E E Tarttelin; R Goliath; J J van Lith-Verhoeven; J Greenberg; R S Ramesar; C B Hoyng; F P Cremers; D A Mackey; S S Bhattacharya; A C Bird; A F Markham; C F Inglehearn
Journal:  Hum Mol Genet       Date:  2001-07-15       Impact factor: 6.150

Review 4.  Retinitis pigmentosa. The Friedenwald Lecture.

Authors:  E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-04       Impact factor: 4.799

5.  Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-thalassemia.

Authors:  G W Hall; S Thein
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

6.  T cell receptor-beta mRNA splicing during thymic maturation in vivo and in an inducible T cell clone in vitro.

Authors:  L Qian; M N Vu; M S Carter; J Doskow; M F Wilkinson
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

7.  RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies.

Authors:  Nina Schaffert; Markus Hossbach; Rainer Heintzmann; Tilmann Achsel; Reinhard Lührmann
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease.

Authors:  Fusako Usuki; Akio Yamashita; Itsuro Higuchi; Tetsuo Ohnishi; Tadafumi Shiraishi; Mitsuhiro Osame; Shigeo Ohno
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

9.  Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.

Authors:  Eliot L Berson; Bernard Rosner; Michael A Sandberg; Carol Weigel-DiFranco; Ann Moser; Robert J Brockhurst; K C Hayes; Chris A Johnson; Ellen J Anderson; Alexander R Gaudio; Walter C Willett; Ernst J Schaefer
Journal:  Arch Ophthalmol       Date:  2004-09

10.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.

Authors:  E L Berson; B Rosner; M A Sandberg; K C Hayes; B W Nicholson; C Weigel-DiFranco; W Willett
Journal:  Arch Ophthalmol       Date:  1993-06
View more
  47 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa.

Authors:  Kentaro Kurata; Katsuhiro Hosono; Yoshihiro Hotta
Journal:  Jpn J Ophthalmol       Date:  2018-01-05       Impact factor: 2.447

3.  Whole exome sequencing of a dominant retinitis pigmentosa family identifies a novel deletion in PRPF31.

Authors:  Adda Villanueva; Jason R Willer; Julien Bryois; Emmanouil T Dermitzakis; Nicholas Katsanis; Erica E Davis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-07       Impact factor: 4.799

4.  Detecting novel genetic mutations in Chinese Usher syndrome families using next-generation sequencing technology.

Authors:  Ling-Hui Qu; Xin Jin; Hai-Wei Xu; Shi-Ying Li; Zheng-Qin Yin
Journal:  Mol Genet Genomics       Date:  2014-09-25       Impact factor: 3.291

5.  DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.

Authors:  Thomas Rio Frio; Amin Bahubeshi; Chryssa Kanellopoulou; Nancy Hamel; Marek Niedziela; Nelly Sabbaghian; Carly Pouchet; Lucy Gilbert; Paul K O'Brien; Kim Serfas; Peter Broderick; Richard S Houlston; Fabienne Lesueur; Elena Bonora; Stefan Muljo; R Neil Schimke; Dorothée Bouron-Dal Soglio; Jocelyne Arseneau; Kris Ann Schultz; John R Priest; Van-Hung Nguyen; H Rubén Harach; David M Livingston; William D Foulkes; Marc Tischkowitz
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

6.  The splicing factor Prp31 is essential for photoreceptor development in Drosophila.

Authors:  Payal Ray; Xiaoyan Luo; Elizabeth J Rao; Amina Basha; Elvin A Woodruff; Jane Y Wu
Journal:  Protein Cell       Date:  2010-04-17       Impact factor: 14.870

7.  Time Course of Disease Progression of PRPF31-mediated Retinitis Pigmentosa.

Authors:  Kelly Kiser; Kaylie D Webb-Jones; Sara J Bowne; Lori S Sullivan; Stephen P Daiger; David G Birch
Journal:  Am J Ophthalmol       Date:  2018-12-21       Impact factor: 5.258

8.  Mutation discovered in a feline model of human congenital retinal blinding disease.

Authors:  Marilyn Menotti-Raymond; Koren Holland Deckman; Victor David; Jaimie Myrkalo; Stephen J O'Brien; Kristina Narfström
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

9.  Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  Jérôme Bouligand; Brigitte Delemer; Annie-Claude Hecart; Geri Meduri; Say Viengchareun; Larbi Amazit; Séverine Trabado; Bruno Fève; Anne Guiochon-Mantel; Jacques Young; Marc Lombès
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

10.  A single-base substitution within an intronic repetitive element causes dominant retinitis pigmentosa with reduced penetrance.

Authors:  Thomas Rio Frio; Terri L McGee; Nicholas M Wade; Christian Iseli; Jacques S Beckmann; Eliot L Berson; Carlo Rivolta
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.